Stem Cell Lung Organoid Differentiation Protocol

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for directing the differentiation of pluripotent stem cells into specific tissues, such as lung tissue, lack precision and efficiency, particularly in replicating the complex structural organization and cellular composition of native lung tissue.

Innovation Solution

The method involves step-wise differentiation of pluripotent stem cells into definitive endoderm, then into ventral-anterior foregut spheroids, and finally into 3-dimensional lung tissue and lung organoids, using specific signaling pathways like Wnt, FGF, BMP, and Hedgehog signaling pathways to activate or inhibit, with small molecules like CHIR99021, FGF4, Noggin, and SAG, to achieve the desired tissue formation.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If conventional differentiation methods are used to generate lung tissue from pluripotent stem cells, then tissue formation occurs, but the structural organization and cellular composition fail to closely resemble native lung tissue

Engineering Contradiction:
Improvestructural organization precisionVSAvoidtissue fidelity to native lung
Core Design Contradiction:
Manufacturing precisionVSReliability

Solution Approach 1:

The differentiation process is divided into distinct sequential stages: definitive endoderm formation, ventral anterior foregut spheroid formation, and lung organoid formation. Each stage uses specific signaling pathway modulations (Wnt activation, FGF activation, BMP inhibition, TGF-beta inhibition, Hedgehog activation) to guide precise structural development, ensuring high fidelity to native lung tissue architecture

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The method performs preliminary actions by first establishing definitive endoderm with specific gene expression profiles (FOXA2, SOX17) before progressing to foregut spheroid formation. This staged preliminary differentiation ensures that each subsequent stage builds upon a properly prepared cellular foundation, achieving precise structural organization

Inventive Principle:
Principle #10Preliminary action

2Productivity

If conventional differentiation methods are used, then lung tissue is generated, but the process lacks efficiency in replicating complex cellular composition

Engineering Contradiction:
Improvedifferentiation efficiencyVSAvoidcellular composition accuracy
Core Design Contradiction:
ProductivityVSManufacturing precision

Solution Approach 1:

The method systematically changes biochemical parameters at each differentiation stage by activating or inhibiting specific signaling pathways (Wnt, FGF, BMP, TGF-beta, Hedgehog) using small molecules. This parameter control enables efficient generation of lung organoids with accurate cellular composition including epithelial cells, mesenchymal cells, and specialized lung cell types

Inventive Principle:
Principle #35Parameter changes

Data Source

PatentUS20200109371A1Compositions and methods for obtaining stem cell derived lung tissue, and related uses therof
Publication Date: 2020.04.09 THE RGT UNIV OF MICHIGAN
  • US20200109371A1 patent drawing
  • US20200109371A1 patent drawing
  • US20200109371A1 patent drawing

AI summary

The invention disclosed herein generally relates to methods and systems for converting stem cells into specific tissue(s) or organ(s) through directed differentiation. In particular, the invention disclosed herein relates to methods and systems for promoting definitive endoderm formation from pluripotent stem cells. The invention disclosed herein further relates to methods and systems for promoting ventral-anterior foregut spheroid tissue formation, 3-dimensional lung tissue formation, and lung organoid tissue formation produced in vitro from the described methods